Addiction Unit, Sørlandet Hospital HF, Kristiansand, Norway.
City Centre Outreach Service, Social and Welfare Services, Oslo, Norway.
PLoS One. 2022 Jun 16;17(6):e0269988. doi: 10.1371/journal.pone.0269988. eCollection 2022.
Cannabis is the most commonly used regulated drug by European youths. Yet, few cannabis-specific interventions have been examined in Europe. The Cannabis Cessation Program (CCP) was developed in Sweden in the 1990s and has been implemented in some Norwegian municipalities. The present study aimed to examine outcomes of this intervention in the Norwegian setting.
The respondents (N = 102) were recruited in four community-based CCPs in Norway. We examined their changes in cannabis use, other substance use, mental distress, well-being, sense of coherence (SoC), and social networks, from baseline (T0) to post-treatment (T1) and up to a 3-month follow-up period (T2). Changes were evaluated with pair-wise t-tests.
Seventy-six participants (75%) completed the 8-week program, according to plan. All participants reported a significant reduction in cannabis use at T1 (average reduction ~16 days per month) and at T2 (N = 59; ~13 days per month). Among those that completed the program, 67% was abstinent from cannabis at T1 and 37% was abstinent at T2. An intention-to-treat analysis showed that 50% (51/102) and 22% (22/102) were abstinent from cannabis use at T1 and T2, respectively. In parallel to abstinence, we observed a substantial reduction in mental distress and an increase in well-being and SoC. Respondents socialized with fewer friends with current substance use, but drug-free social networks were not expanded.
Our findings suggested that the CCP was a valuable, low-threshold manual-based intervention for cannabis use disorders. It showed considerable potential for reducing individuals' cannabis use.
Clinicaltrials.gov no. NCT04989205. Registered 12 July 2021, i.e., the study was retrospectively registered.
大麻是欧洲青少年最常使用的管制药物。然而,在欧洲,很少有专门针对大麻的干预措施得到研究。大麻戒除计划(CCP)于 20 世纪 90 年代在瑞典开发,并在一些挪威城市实施。本研究旨在检验该干预措施在挪威环境中的效果。
本研究的参与者(N=102)是从挪威四个基于社区的 CCP 中招募的。我们考察了他们在基线(T0)到治疗结束(T1)以及 3 个月随访(T2)期间,在大麻使用、其他物质使用、心理困扰、幸福感、整体感(SoC)和社交网络方面的变化。采用配对 t 检验评估变化。
根据计划,76 名参与者(75%)完成了 8 周的项目。所有参与者均报告称在 T1 时大麻使用量显著减少(平均每月减少约 16 天),T2 时(N=59;每月减少约 13 天)也显著减少。在完成项目的参与者中,67%在 T1 时大麻戒除,37%在 T2 时大麻戒除。意向治疗分析显示,50%(51/102)和 22%(22/102)在 T1 和 T2 时大麻使用戒除。随着戒除的发生,我们观察到心理困扰显著减少,幸福感和整体感增加。受访者与目前有物质使用的朋友交往减少,但没有扩大无毒品的社交网络。
我们的研究结果表明,CCP 是一种有价值的、低门槛的基于手册的大麻使用障碍干预措施。它显示出相当大的减少个人大麻使用的潜力。
Clinicaltrials.gov 编号 NCT04989205。于 2021 年 7 月 12 日注册,即本研究为回顾性注册。